Article info

ACUTE MYOCARDIAL INFARCTION: REPERFUSION TREATMENT
Free
  1. Correspondence to:
    William Wijns, MD, Cardiovascular Centre, OLV Hospital, 164, Moorselbaan, 9300 AALST, Belgium;
    william.wijns{at}olvz-aalst.be
View Full Text

Citation

Ribichini F, Wijns W
ACUTE MYOCARDIAL INFARCTION: REPERFUSION TREATMENT

Publication history

  • First published September 1, 2002.
Online issue publication 
September 01, 2002
  •  
    Acute myocardial infarction: reperfusion treatment
    Flavio Ribichini and William Wijns
     

    Web-only References

    [View as PDF]

    (1) Calif RM. Glycoprotein IIb/IIIa blockade and thrombolytics: early lessonsfrom the SPEED and GUSTO IV trials. Am Heart J 1999;138:S12-S15

    (2) Barron HV, Bowlby LJ, Breen T, et al for the National Registry of Myocardial Infarction 2 Investigators. Use of reperfusion therapy for acute myocardial infarction in the United States. Data from the National Registry of Myocardial Infarction 2. Circulation 1998;97:1150-1156

    (3) Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993;328:673-679

    (4) Zijlstra F, de Boer MJ, Hoorntje JCA, et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993; 328:680-684

    (5) Gibbons RJ, Holmes DR, Reeder GS, et al. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med 1993;328:685-691

    (6) ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;2:349-360

    (7) Rawles J, on behalf of the GREAT Study. Halving of mortality at 1 year by domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial (GREAT). J Am Coll Cardiol 1994;23:1-5

    (8) Ryan TJ, Antman EM, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel B, Russell RO, Smith III EE, Weaver WD. 1999 Update. ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1999;34:890-911

    (9) Ribichini F, Steffenino G, Dellavalle A, et al. Comparison of thrombolytic therapy and primary coronary angioplasty with liberal stenting for inferior myocardial infarction with precordial ST-segment depresision. J Am Coll Cariol 1998;32:1687-1694

    (10) Horie H, Takahashi M, Minai K, et al. Long-term beneficial effect of late reperfusion for acute myocardial infarction with percutaneous transuminal angioplasty. Circulation 1998;98:2377-2382

    (11) Every NR, Parsons LS, Hlatky M, et al for the Myocardial Infarction Triage and Intervention Investigators. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. N Engl J Med 1996;335:1253-1260

    (12) Vogt A, Niederer W, Pfafferott C, et al on behalf of the study group of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausarzte (ALKK). Direct percutaneous transluminal coronary angioplasty in acute myocardial infarction. Predictors of short-term outcome and the impact of coronary stenting. Eur Heart J 1998;19:917-921

    (13) Zijlstra F. Long-term benefit of primary angioplasty compared to thrombolytic therapy for acute myocardial infarction. Eur Heart J 2000;21:1487-1489

    (14) Grines CL, Cox DA, Stone GW, et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med 1999;341:1949-1956

    (15) Stone GW, Grines CL, Cox DA, et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 2002;346:957-966

    (16) Neumann FJ, Kastrati A, Schmitt C, et al Effects of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis after the placement of coronary stents following acute myocardial infarction. J Am Coll Cardiol 2000;35:915-921

    17) Kennedy JW, Stadius ML. Combined thrombolytic therapy and platelet glycoprotein IIb/IIIa inhibitor therapy for acute myocardial infarction. Will the pharmacological therapy ever equal primary angioplasty? Circulation 1999;99:2714-2716

    18) Ohman EM, Kleiman NS, Gacioch G, et al for the IMPACT-AMI Investigators. Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with integrilin in acute myocardial infarction: results of a randomized, placebo-controlled, dose-ranging trial. Circulation 1997;95:846-854

    19) Van de Werf F, Neuhaus KL. Late-breaking clinical trials II: coronary artery disease. Assessment of the safety and efficacy of a new thrombolytic: TNK-tPA Trial (ASSENT-2), and A phase III Trial of novel thrombolytic lanoteplase (nPA): In-Time-II. J Am Coll Cardiol 1999;34:4-5

    20) Califf RM. Ten years of benefit from a one-hour intervention. Circulation 1998;98:264-2651

    21) Blankenship JC, Almqvist AK. Cardiovascular complications of thrombolytic therapy in patients with a mistaken diagnosis of acute myocardial infarction. J Am Coll Cardiol 1989;14:1579-1582

    22) Wilcox RG, Olsson CG, Skene AM, Von Der Lippe G, Jensen G, Hampton JR. Trial of tissue plasminogen activator for the mortality reduction in acute myocardial infarction. AngloScandinavian Study of Early Thrombolysis (ASSET). Lancet 1988;2:525-530

    (23) Liem AY, Van�T Hof AWJ, Hoorntje JCA, et al. Influence of treatment delay on infarct size and clinical outcome inpatients with acute myocardial infarction treated with primary angioplasty. J Am Coll Cardiol 1998;32:629-63

    (24) Brodie BR, Stuckey TD, Wall TC, et al. Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 1998;32:1312-1319

    (25) Berger PB, Ellis SG, Holmes DR, et al for the GUSTO-II Investigators. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction. Results from the Global Use of Strategies to Open Occluded Arteries in 47 Acute Coronary Syndromes (GUSTO-IIb) Trial. Circulation 1999;100:14-20

    (26) Zijlstra F, Patel A, Jones M, et al. Clinical characteristics and outcome of patients with early, intermediate and late presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J 2002;23:550-557

    (27) Fibrinolytic Therapy Trialists� (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343:311-322

    (28) Zijlstra F. Acute myocardial infarction: primary angioplasty. Heart 2001;85:705-709

    (29) Nunn CM, O�Neill WW, Rothbaum D, et al for the Primary Angioplasty in Myocardial Infarction I Study Group.Long-term outcome after primary angioplasty: report from the Primary Angioplasty in Myocardial Infarction (PAMI-I) Trial. J Am Coll Cardiol 1999;33:640-646

    (30) Birkhead JS. Thrombolytic treatment for myocardial infarction: an examination of practice in 39 United Kingdom hospitals. Myocardial Infarction Audit Group. Heart 1997;78:28-33

    (31) Boyle RM. Immediate angioplasty in the United Kingdom. The time has not yet come. International Roundup. BHJ 1995;73:413-414

    (32) Zahn R, Schiele R, Seidl K, et al. Spectrum of reperfusion strategies and factors influencing the use of primary angioplasty in patients with acute myocardial infarction admitted to hospitals with the facilities to perform primary angioplasty. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group. Heart 1999;82:420-425

    (33) Wagner S, Schneider S, Schiele R, et al. Acute myocardial infarction in Germany between 1996 and 1998 therapy and intrahospital course. Results of the Myocardial Infarction Registry (MIR) in Germany. Z Kardiol 1999;88:857-867

    (34) Monassier JP, Hanania G, Khalife K, et al. Therapeutic strategies in acute myocardial infarction. Results of the STIM 93 Registry. Arch Mal Coeur Vaiss 1996;89:281-289

    (35) Danchin N, Vaur L, Genes N, et al. Management of acute myocardial infarction in intensive care units in 1995: a nationwide French survey of practice and early hospital results. J Am Coll Cardiol 1997;30:1598-1605

    (36) Juliard JM, Himbert D, Aubry P, et al. Orientated management towards reperfusion in the acute phase of myocardial infarction. Results in a cohort of 700 consecutive patients. Arch Mal Coeur Vaiss 1997;90:337-343

    (37) Behar S. Use of thrombolysis for myocardial infarction in Israel. Harefuah 1992;122:753-756

    (38) Reikvam A, Ketley D. Thrombolytic eligibility in acute myocardial infarction patients admitted to Norwegian hospitals. Int J Cardiol 1997;61:79-83

    (39) Herlitz J, Abrahamsson P, Dellborg M, et al. Long-term survival after development of acute myocardial infarction has improved after a more widespread use of thrombolysis and aspirin. Cardiology 1999;91:250-255

    (40) Bosch X, Sambola A, Aros F, et al. Use of thrombolytic treatment in patients with acute myocardial infarction in Spain. Observations from the PRIAMHO Study. Rev Esp Cardiol 2000;53:490-501

    (41) Cabades A, Echanove I, Cebrian J, et al. The characteristics, management and prognosis of the acute myocardial infarct patient in the Valencian Community in 1995: the results of the PRIMVAC Registry. Rev Esp Cardiol 1999;52:123-133

    (42) French JK, Williams BF, Hart HH, et al. Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction. BMJ 1996;312:1637-1641

    (43) Hooi H. Review of Emergency department thrombolytic therapy and changes in inpatient mortality of acute myocardial infarction on NSW Central Coast 1986 to 1994-96. Aust N Z Med 1999;29:505-511

    (44) Van de Werf F, Topol EJ, Lee KL, et al. Variations in the patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO Trial. JAMA 1995;273:1586-1591

    (45) Zahn R, Schuster S, Scheile R, et al for the MITRA Study Group. Comparison of primary angioplasty with conservative therapy in patients with acute myocardial infarction and contraindications for thrombolytic therapy. Cathet Cardiovasc Intervent 1999;46:127-133

    (46) Aversano T, Aversano LT, Passamani E, et al. Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery. JAMA 2002;287:1943-1951

    (47) Ito H, Okamura A, Iwakura K, et al. Myocardial persufion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation 1996;93:1993-1999

    (48) Stone GW, Grines CL, Rothbaum D, et al. Analysis of the related costs and effectiveness of primary angioplasty compared to tissue plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. J Am Coll Cardiol 1997;29:901-907

    (49) Grines CL, Marsalese DL, Brodie B, et al. Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. J Am Coll Cardiol 1998;331:967-972

    (50) Meijer A, Verheugt FWA, Werter CJPJ, et al. Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study: results of the APRICOT Study. Circulation 1993;87:1524-1530

    (51) Roberts WC, Buja LM. The frequency and significance of coronary arterial thrombi and other observations in fatal acute myocardial infarction. A study of 107 necropsy patients. Am J Med 1972;52: 425-443

    (52) Murakami T, Mizuno S, Takahashi Y, et al. Intracoronary aspiration thrombectomy for acute myocardial infarction. Am J Cardiol 1998;82:839-844

    (53) Loubeyre C, Lefevre T, Louvard Y, et al. Outcome after combined reperfusion therapy for acute myocardial infarction, combining pre-hospital thrombolysis with immediate percutaneous coronary intervention and stent. Eur Heart J 2001;22:1128-1135

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.